Bicara Therapeutics Inc (BCAX)
Operating Cash Flow (Statement)
-$134.85M
TTM · Period ending: · USD
BCAX Operating Cash Flow (Statement)
Latest reported-$134.85Mperiod ending
Latest reported-$134.85Mperiod ending
BCAX TTM Cash from Operations (-$45.63M → -$134.85M)
TTM operating cash flow (statement)
High-resolution chart · PNG
BCAX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -134,848,000 | |
| -116,236,000 | |
| -106,834,000 | |
| -112,980,000 | |
| -100,956,000 | |
| -88,270,000 | |
| -74,751,000 | |
| -52,755,000 | |
| -46,063,000 | |
| -46,685,000 | |
| -45,628,000 |